CNBC's Darren Rovell reports on how shares of GNC Holdings and Vitamin Shoppe are faring since the FDA sent warning letters regarding an ingredient in some of the companies' products.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT